---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-018514"
form_type: "8-K"
ticker: "RLAY"
cik: "0001812364"
company_name: "Relay Therapeutics, Inc."
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:28:38.855346+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Relay Therapeutics prices $300M public offering of 11.32M shares at $26.50 per share

## Summary
- Priced public offering of 11,320,755 shares at $26.50/share; gross proceeds ~$300M.
- Net proceeds expected ~$284.5M after underwriting discounts and expenses.
- Underwriters granted 30-day option to buy up to 1,698,113 additional shares.
- Offering expected to close on September 15, 2022; Goldman Sachs, J.P. Morgan, Cowen, BofA act as managers.
- All shares sold by Relay Therapeutics; shelf registration effective.

## SEC filing metadata
- accession: 0000950170-22-018514
- form_type: 8-K
- ticker: RLAY
- cik: 0001812364
- company_name: Relay Therapeutics, Inc.
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812364/000095017022018514/0000950170-22-018514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812364/000095017022018514/rlay-20220912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-018514
- JSON: https://secwatch.observer/filing/0000950170-22-018514.json
- Plain text: https://secwatch.observer/filing/0000950170-22-018514.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.